BACE2 expression increases in human neurodegenerative disease.
about
A genetic cause of Alzheimer disease: mechanistic insights from Down syndromeCommon transcriptional signatures in brain tissue from patients with HIV-associated neurocognitive disorders, Alzheimer's disease, and Multiple SclerosisBridging integrator 1 (BIN1) protein expression increases in the Alzheimer's disease brain and correlates with neurofibrillary tangle pathologyOpportunities and Limitations of Modelling Alzheimer's Disease with Induced Pluripotent Stem Cellsβ-Secretases, Alzheimer's Disease, and Down Syndrome.Identification of BACE2 as an avid ß-amyloid-degrading proteaseA rare de novo duplication of chromosome 21q22.12 → q22.3 with other concomitant deletion and duplication of small fragments in 21q associated with Down syndrome: Prenatal diagnosis, molecular cytogenetic characterizationPostmortem Pittsburgh Compound B (PiB) binding increases with Alzheimer's disease progression.Transgenic models of Alzheimer's disease: better utilization of existing models through viral transgenesis.β-Secretase: its biology as a therapeutic target in diseasesAging in Down Syndrome and the Development of Alzheimer's Disease Neuropathology.Polymorphisms in BACE2 may affect the age of onset Alzheimer's dementia in Down syndrome.Identification of a five B cell-associated gene prognostic and predictive signature for advanced glioma patients harboring immunosuppressive subtype preference.A Novel Small Molecule Modulator of Amyloid Pathology.A Translational Systems Pharmacology Model for Aβ Kinetics in Mouse, Monkey, and Human.A ketogenic diet improves motor performance but does not affect β-amyloid levels in a mouse model of Alzheimer's disease.Down syndrome, beta-amyloid and neuroimaging.
P2860
Q26798983-CD5980C6-2845-4B74-9FB4-80B9F2B24C63Q27007041-C1E2B927-E855-46C7-88FA-27C6D70F86A9Q34345159-347D53F6-2AB3-4C1E-B544-A44A8D3E02AAQ35750557-FC905CBF-BA09-4A5E-B00F-E3D189334972Q35821455-FF2BEFB3-7A1C-4670-99D3-2532B7456C0FQ36316174-8B7DEB43-C231-41B4-9EE0-D897FFBD6B66Q36690762-2B220A13-2619-455D-BA4B-FB592B31B2A8Q36713678-A9CDD812-0B67-4552-9D7D-8A381607DCE1Q36950042-ADBA5EDC-B7D3-47DB-B83B-987F58CB58D7Q36951145-60B127E9-981A-42B3-ABE7-8CB616103B10Q37102001-0D4DAE32-E900-48CC-9F8C-379B22340272Q37671444-6C3CE232-5F7D-47F5-A735-733C81767625Q37687506-29B05801-5F16-457B-B0D6-1E08516FFE53Q39779155-9E3068F5-4281-4117-B226-4A33965EE1D1Q42621620-B9D9201A-D8FC-402B-BF1B-58A62E9731B8Q42910540-235123F6-2B29-4FAF-9EC0-504E97D7F95CQ48102481-AD5932AD-8021-46AF-BDF8-766D339A6B43
P2860
BACE2 expression increases in human neurodegenerative disease.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
BACE2 expression increases in human neurodegenerative disease.
@ast
BACE2 expression increases in human neurodegenerative disease.
@en
type
label
BACE2 expression increases in human neurodegenerative disease.
@ast
BACE2 expression increases in human neurodegenerative disease.
@en
prefLabel
BACE2 expression increases in human neurodegenerative disease.
@ast
BACE2 expression increases in human neurodegenerative disease.
@en
P2093
P2860
P1476
BACE2 expression increases in human neurodegenerative disease.
@en
P2093
Amy L S Dowling
Angela Spinelli
Ashley L Laux
Christopher J Holler
Christopher R Simmons
Dana M Niedowicz
Elizabeth Head
Louis B Hersh
M Paul Murphy
Moshe Khurgel
P2860
P304
P356
10.1016/J.AJPATH.2011.09.034
P407
P577
2011-11-07T00:00:00Z